# Pharmacogenomic Data Submissions — Companion Guidance - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/pharmacogenomic-data-submissions-companion-guidance/26f5c4db-2ae3-46b8-ae62-dbb909250a16

> FDA guidance document: Pharmacogenomic Data Submissions — Companion Guidance. Issue date: August 28, 2007. Get complete insights and analysis.

---

## Details

- Title: Pharmacogenomic Data Submissions — Companion Guidance
- Communication Type: Guidance Document
- Product Type: drugs
- Office Name: Center for Drug Evaluation and Research
- Office URL: /offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
- Issue Date: 2007-08-28
- Last Changed: 2020-04-27
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-2007-D-0136">FDA-2007-D-0136</a>

## Related Documents

- [Malaria: Developing Drugs for Treatment: Draft Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/malaria-developing-drugs-for-treatment-draft-guidance-for-industry/3edfcacf-7736-421e-9b04-b883ec5cc173)
- [Drug Master Files Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/drug-master-files-guidance-for-industry/7dfd5140-3156-43f2-bdb9-d23ad597311c)
- [Pharmacogenomic Data Submissions](https://www.globalkeysolutions.net/guidances/guidance-document/pharmacogenomic-data-submissions/9a29ff18-0847-4eaa-b84e-2e4b7bd5d29e)